Because no obvious differences between tumor cells and primary cells were detected in our experimental data sets, we hypothesized that adjustments of other pathway constituents can compensate the attenuated responsiveness upon TNFR1 reduction. This evidence concerns the gene TNFRSF1A and neoplasm.